BPC 157 Arginate Therapy for your Healing Simply Wellness The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide BPC 157 benefits, dosage, and side effects Federal Register :: Revocation of Emergency Use of a Drug During the COVID 19 Pandemic; Availability The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA takes first step in possible reversal of ban on some peptides The Washington Post